Telomerase inhibitors and methods of use thereof

Details for Australian Patent Application No. 2009302385 (hide)

Owner President and Fellows of Harvard College

Inventors Gude-Rodriguez, Lourdes; Verdine, Gregory L.; Stanton, Shaunna Syu-Mei

Agent Pizzeys

Pub. Number AU-A-2009302385

PCT Pub. Number WO2010/042636

Priority 61/103,430 07.10.08 US

Filing date 7 October 2009

Wipo publication date 15 April 2010

International Classifications

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/042636 Priority application(s): WO2010/042636

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009302387-HPMA - docetaxel or gemcitabine conjugates and uses therefore

2009302383-Use of IL-20 antagonists for treating rheumatoid arthritis and osteoporosis